1. Home
  2. SOC vs ATRC Comparison

SOC vs ATRC Comparison

Compare SOC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOC
  • ATRC
  • Stock Information
  • Founded
  • SOC 2020
  • ATRC 2000
  • Country
  • SOC United States
  • ATRC United States
  • Employees
  • SOC N/A
  • ATRC N/A
  • Industry
  • SOC
  • ATRC Medical/Dental Instruments
  • Sector
  • SOC
  • ATRC Health Care
  • Exchange
  • SOC Nasdaq
  • ATRC Nasdaq
  • Market Cap
  • SOC 2.0B
  • ATRC 1.7B
  • IPO Year
  • SOC N/A
  • ATRC 2005
  • Fundamental
  • Price
  • SOC $19.10
  • ATRC $34.81
  • Analyst Decision
  • SOC Buy
  • ATRC Strong Buy
  • Analyst Count
  • SOC 3
  • ATRC 10
  • Target Price
  • SOC $30.00
  • ATRC $49.60
  • AVG Volume (30 Days)
  • SOC 5.9M
  • ATRC 429.2K
  • Earning Date
  • SOC 11-13-2025
  • ATRC 10-28-2025
  • Dividend Yield
  • SOC N/A
  • ATRC N/A
  • EPS Growth
  • SOC N/A
  • ATRC N/A
  • EPS
  • SOC N/A
  • ATRC N/A
  • Revenue
  • SOC N/A
  • ATRC $499,946,000.00
  • Revenue This Year
  • SOC N/A
  • ATRC $16.32
  • Revenue Next Year
  • SOC $184.34
  • ATRC $12.37
  • P/E Ratio
  • SOC N/A
  • ATRC N/A
  • Revenue Growth
  • SOC N/A
  • ATRC 16.28
  • 52 Week Low
  • SOC $16.26
  • ATRC $25.57
  • 52 Week High
  • SOC $35.00
  • ATRC $43.11
  • Technical
  • Relative Strength Index (RSI)
  • SOC 38.61
  • ATRC 46.55
  • Support Level
  • SOC $17.25
  • ATRC $33.45
  • Resistance Level
  • SOC $20.32
  • ATRC $35.69
  • Average True Range (ATR)
  • SOC 1.83
  • ATRC 1.34
  • MACD
  • SOC -0.21
  • ATRC -0.22
  • Stochastic Oscillator
  • SOC 23.99
  • ATRC 27.87

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: